NFE2L2 and pulmonary fibrosis: Investigations on an in vivo bleomycin treatment-mediated pulmonary fibrosis model discovered a clock-‘gated’ pulmonary response towards oxidative injury, manifesting a severe fibrotic effect on the application of bleomycin at a circadian nadir in NRF2 levels.